Argenica Therapeutics News and Activities

Argenica Therapeutics is a company listed under the stock ticker AGN (AU).

View the org chart displaying its 9 main executives

Most searched biographies at Argenica Therapeutics

• Liz Dallimore, Director, Chief Executive Officer and Managing Dire...
• Terry Budge, Non-Executive Director
• Mark Etherton, Director

Popular executive movements at Argenica Therapeutics

• Rob Black, Director, has left the company  (posted on March 3 2025).
• Jeannie Joughin has joined the company as Non-Executive Director  (posted on December 3 2024).
• Liddy Mccall, Non-Executive Director, will retire on Nov. 12, 2024  (posted on October 25 2024).

Click here to view some more movements at Argenica Therapeutics

Create your alert
to follow the executive moves at Argenica Therapeutics.

Argenica Therapeutics has 2,341 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Regeneron Pharmaceuticals has announced the acquisition of 23andMe  (posted on May 20 2025).
• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Argenica Therapeutics

Social media about Argenica Therapeutics

• Argenica Therapeutics on Wikipedia, Google News & Yahoo Finance
• Argenica Therapeutics on LinkedIn, Twitter & YouTube